In people with type 2 diabetes, its approved to: improve blood sugar levels when used along with changes in diet and exercise reduce the risk of hospitalization for heart failure in people with heart disease or risk factors for heart disease In people with heart failure with or without type 2 diabetes, its approved to: reduce the risk of either hospitalization for heart failure or cardiovascular death* in people with reduced ejection fraction (EF) For people with chronic (long-lasting) kidney disease that may worsen, Farxiga is approved to reduce the risk of: lowered glomerular filtration rate (GFR), which can indicate poor kidney health end stage kidney disease cardiovascular death hospitalization for heart failure Its important to note that Farxiga isnt approved to treat type 1 diabetes
They even show promise in curbing addiction, according to The NIH Catalyst
Nausea, vomiting, diarrhea, constipation, and injection site reactions all appear in the safety data with frequency numbers attached
Our comprehensive support in formulation and manufacturing ensures you can capture the growing market of health-conscious consumers seeking safe and effective performance enhancers
This ongoing support helps patients stay informed, supported, and confident as they move through each phase of treatment
Wound Healing : L-arginine is involved in various aspects of the wound healing process